SCHEMBL11249609

SCHEMBL11249609

CCCCCCCCCCCCCCCCNc1ccc(C(=O)OCC)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 3/20 0.46
LMNA P02545 3/20 0.45
CYP1A2 P05177 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CRBN Q96SW2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ABL1 P00519 1/20 0.44
TSHR P16473 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 1/20 0.43
EGFR P00533 1/20 0.43
PNLIP P16233 1/20 0.42
MAOA P21397 1/20 0.41
CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11251685 1.00 PLK1 (0.46) PLK1LMNACYP1A2KDM4ECRBN
SCHEMBL11313614 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11306884 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11307880 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11315370 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11318044 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11307809 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11313424 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11313529 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1
SCHEMBL11319758 0.89 PLK1 (0.48) PLK1LMNACYP1A2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4333940-A Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development AMERICAN CYANAMID COMPANY (US) 1982-06-08 US disclosed
US-4243609-A ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1981-01-06 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed